202 related articles for article (PubMed ID: 32855097)
1. Human-Derived Model Systems in Gynecological Cancer Research.
Lõhmussaar K; Boretto M; Clevers H
Trends Cancer; 2020 Dec; 6(12):1031-1043. PubMed ID: 32855097
[TBL] [Abstract][Full Text] [Related]
2. Organoid models in gynaecological oncology research.
Semertzidou A; Brosens JJ; McNeish I; Kyrgiou M
Cancer Treat Rev; 2020 Nov; 90():102103. PubMed ID: 32932156
[TBL] [Abstract][Full Text] [Related]
3. Melanoma of the lower genital tract: Prognostic factors and treatment modalities.
Gadducci A; Carinelli S; Guerrieri ME; Aletti GD
Gynecol Oncol; 2018 Jul; 150(1):180-189. PubMed ID: 29728261
[TBL] [Abstract][Full Text] [Related]
4. Organoids of the female reproductive tract.
Chumduri C; Turco MY
J Mol Med (Berl); 2021 Apr; 99(4):531-553. PubMed ID: 33580825
[TBL] [Abstract][Full Text] [Related]
5. Organoid systems to study the human female reproductive tract and pregnancy.
Alzamil L; Nikolakopoulou K; Turco MY
Cell Death Differ; 2021 Jan; 28(1):35-51. PubMed ID: 32494027
[TBL] [Abstract][Full Text] [Related]
6. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
7. Gynecological sarcomas.
DiSaia PJ; Pecorelli S
Semin Surg Oncol; 1994; 10(5):369-73. PubMed ID: 7997731
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and VDR in Gynecological Cancers-A Systematic Review.
Deuster E; Jeschke U; Ye Y; Mahner S; Czogalla B
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113037
[TBL] [Abstract][Full Text] [Related]
9. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool RM; Plotti F; Simoncini T; Terranova C
Int J Gynecol Cancer; 2020 Apr; 30(4):428-433. PubMed ID: 32046979
[TBL] [Abstract][Full Text] [Related]
10. Non-uterine gynecological sarcomas.
Leppien G
Arch Gynecol Obstet; 1987; 241(1):25-32. PubMed ID: 3314737
[TBL] [Abstract][Full Text] [Related]
11. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
12. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Oct; 27(8S):S1-S9. PubMed ID: 30819761
[TBL] [Abstract][Full Text] [Related]
13. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G
Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
15. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
16. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy.
Cocomazzi G; Del Pup L; Contu V; Maggio G; Parmegiani L; Ciampaglia W; De Ruvo D; Faioli R; Maglione A; Baldini GM; Baldini D; Pazienza V
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396914
[TBL] [Abstract][Full Text] [Related]
17. Treatment modalities for gynecological cancers.
Robertson C
Semin Oncol Nurs; 1986 Nov; 2(4):275-80. PubMed ID: 3641348
[No Abstract] [Full Text] [Related]
18. EMT-Inducing Molecular Factors in Gynecological Cancers.
Campo L; Zhang C; Breuer EK
Biomed Res Int; 2015; 2015():420891. PubMed ID: 26356073
[TBL] [Abstract][Full Text] [Related]
19. [Grading of gynecological tumors : Current aspects].
Horn LC; Mayr D; Brambs CE; Einenkel J; Sändig I; Schierle K
Pathologe; 2016 Jul; 37(4):337-51. PubMed ID: 27379622
[TBL] [Abstract][Full Text] [Related]
20. Applications of CRISPR-Cas9 in gynecological cancer research.
Zhang W; Liu Y; Zhou X; Zhao R; Wang H
Clin Genet; 2020 Jun; 97(6):827-834. PubMed ID: 32040210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
